Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Mehta

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
BMJ (Clinical Research Ed.)|August 28, 2012
Transfer of high cost drugs to NICE risks fragmentation of care of rare diseasesChris J Hendriksz, D A Hughes, A B Mehta, et al.
Leukemia|April 22, 2006
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitroA J Steele, D T Jones, K Ganeshaguru, et al.
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
BMJ (Clinical Research Ed.)|August 28, 2012
Transfer of high cost drugs to NICE risks fragmentation of care of rare diseasesChris J Hendriksz, D A Hughes, A B Mehta, et al.
Leukemia|April 22, 2006
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitroA J Steele, D T Jones, K Ganeshaguru, et al.
British Journal of Haematology|February 13, 2001
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformationG Jackson, P Taylor, G M Smith, et al.
Pageof 14